켄터키의 전이성 암 임상 시험
전이성 암 관련 연구 17개가 켄터키 내 여러 지역에서 참여자를 모집하고 있습니다.
켄터키의 도시
공식 연구 텍스트(영어)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05564377Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05372614Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Kentucky Markey Cancer Center, Lexington
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06943755Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Baptist Health Hardin, Elizabethtown
- Frankfort BHMG Medical Oncology Office, Frankfort
- Baptist Health Lexington, Lexington
- 외 9개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07222800A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Kentucky Research Foundation, Lexington
- University of Kentucky Healthcare - Markey Cancer Center, Lexington
- University of Kentucky Medical Center, Lexington
- 외 1개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06989437A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Saint Elizabeth Medical Center Edgewood, Edgewood
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Baptist Health Lexington, Lexington
- Norton Women's and Children's Hospital, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Edgewood
- Research Site, Louisville
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06311214A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- St. Elizabeth Healthcare, Edgewood
- Norton Cancer Institute, Louisville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06769698A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Lexington
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07129252A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Norton Cancer Institute, Louisville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT05719558Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- UK Markey Cancer Center, Lexington
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05283330Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Mercy Health-Paducah Cancer Center, Paducah
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT06757634A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Kentucky Markey Cancer Center, Lexington
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- Norton Cancer Institute, Louisville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 12. 19. 업데이트됨 · NCT05270213ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.